Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aurinia Pharm Ord (AUPH)

Aurinia Pharm Ord (AUPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,387,405
  • Shares Outstanding, K 143,179
  • Annual Sales, $ 175,510 K
  • Annual Income, $ -78,020 K
  • EBIT $ -23 M
  • EBITDA $ -12 M
  • 60-Month Beta 1.41
  • Price/Sales 8.25
  • Price/Cash Flow N/A
  • Price/Book 3.73

Options Overview Details

View History
  • Implied Volatility 57.18% ( -0.95%)
  • Historical Volatility 58.80%
  • IV Percentile 38%
  • IV Rank 25.34%
  • IV High 121.14% on 12/14/23
  • IV Low 35.48% on 10/15/24
  • Put/Call Vol Ratio 0.16
  • Today's Volume 924
  • Volume Avg (30-Day) 2,276
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 69,677
  • Open Int (30-Day) 63,159

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.07
  • Number of Estimates 3
  • High Estimate 0.16
  • Low Estimate -0.06
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +136.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.87 +18.49%
on 11/18/24
10.67 -12.61%
on 12/10/24
+1.05 (+12.62%)
since 11/13/24
3-Month
6.64 +40.44%
on 10/10/24
10.67 -12.61%
on 12/10/24
+2.29 (+32.65%)
since 09/13/24
52-Week
4.71 +97.98%
on 04/18/24
10.67 -12.61%
on 12/10/24
+0.57 (+6.57%)
since 12/13/23

Most Recent Stories

More News
Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options

Investors in Aurinia Pharmaceuticals Inc. AUPH need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2025 $20 Put had some of the highest implied...

AUPH : 9.38 (-3.20%)
Aurinia Pharma Surges Pre-Market After Director Kevin Tang Discloses $10M Stock Buy: Retail Confidence Spikes

Aurinia has been under the spotlight recently due to significant restructuring efforts.

AUPH : 9.38 (-3.20%)
Insider Purchase: Director at $AUPH (AUPH) Buys 300,000 Shares

KEVIN TANG, a director at $AUPH ($AUPH), bought 300,000 shares of the company on 12-05-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings...

AUPH : 9.38 (-3.20%)
10 Stocks Retailers On Stocktwits Are Most Bullish/Bearish About To Start The Week

As the new week unfolds, earnings and economic data will again dictate sentiment.

MARA : 23.05 (+2.08%)
BLK : 1,056.45 (-0.22%)
NFLX : 913.69 (-1.28%)
PDD : 101.57 (-2.95%)
AUPH : 9.38 (-3.20%)
CKPT : 3.68 (-3.16%)
EVH : 11.28 (-1.05%)
EBS : 8.46 (-2.65%)
BIDU : 90.23 (-0.10%)
SPY : 602.89 (-0.24%)
COIN : 314.18 (+0.39%)
Aurinia Pharmaceuticals Soars After Earnings Beat, Strategic Overhaul: Retail Sentiment Turns Extremely Bullish

Aurinia plans to slash 45% of its entire workforce with an aim to save more than $40 million in annual operating expenses.

IWO : 301.86 (-1.00%)
AUPH : 9.38 (-3.20%)
IWM : 232.43 (-0.96%)
Aurinia: Q3 Earnings Snapshot

Aurinia: Q3 Earnings Snapshot

AUPH : 9.38 (-3.20%)
Aurinia: Q2 Earnings Snapshot

Aurinia: Q2 Earnings Snapshot

AUPH : 9.38 (-3.20%)
Why Aurinia Pharmaceuticals Stock Is Slumping Today

The biotech's premium valuation doesn't seem to be sitting well with investors.

AUPH : 9.38 (-3.20%)
Why Aurinia Pharmaceuticals Stock Is Marching Higher Friday

The biotech's board is exploring strategic alternatives to boost shareholder value.

NVS : 98.37 (-0.22%)
BMY : 55.64 (-1.14%)
AUPH : 9.38 (-3.20%)
S&P Futures Climb Ahead of Key U.S. Inflation Data

September S&P 500 futures (ESU23) are trending up +0.33% this morning as market participants awaited a reading on the Federal Reserve’s preferred inflation gauge.

ESU23 : 4,491.72s (-0.32%)
WFC : 70.31 (-0.69%)
JPM : 240.07 (-0.60%)
BAC : 45.58 (-1.09%)
OXY : 47.82 (-0.77%)
MU : 101.38 (+3.20%)
ENGI.P.DX : 15.225 (+0.77%)
NKE : 76.95 (-1.30%)
ACCD : 3.45 (-0.86%)
AUPH : 9.38 (-3.20%)
CCL : 25.88 (-1.15%)
NVDA : 133.42 (-2.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

See More

Key Turning Points

3rd Resistance Point 10.47
2nd Resistance Point 10.31
1st Resistance Point 10.00
Last Price 9.38
1st Support Level 9.53
2nd Support Level 9.37
3rd Support Level 9.06

See More

52-Week High 10.67
Last Price 9.38
Fibonacci 61.8% 8.39
Fibonacci 50% 7.69
Fibonacci 38.2% 6.99
52-Week Low 4.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar